Literature DB >> 9717966

Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression.

S L Giannini1, W Al-Saleh, H Piron, N Jacobs, J Doyen, J Boniver, P Delvenne.   

Abstract

We have addressed the notion that the progression of cancer of the uterine cervix is associated with a preferential constraint on the development of a type 1 cellular mediated response, which is necessary to efficiently eliminate (pre)neoplastic cells. Based on the importance of cytokines in the regulation of an appropriate immune response, we have evaluated the expression of IL-12p40, IL-10 and transforming growth factor-beta 1 (TGF-beta1). Using reverse transcriptase-polymerase chain reaction (RT-PCR), the expression of these three cytokines was evaluated in both low-grade (LG) and high-grade (HG) cervical squamous intraepithelial lesions (SIL) and in normal exocervix and transformation zone biopsies. Our results show that the average level of IL-12 increases within both the LG and HG SIL, compared with both control groups. Interestingly, the percentage of HG SIL expressing IL-12p40 was lower compared with LG SIL. In contrast, the expression of IL-10 increased in parallel with the severity of the lesion to a maximal level in HG SIL. Using immunohistochemistry, we ascertained the presence of IL-12 protein in SIL and IL-10 protein in the transformation zone and SIL biopsies. Both IL-12- and IL-10-producing cells were localized in the stroma, not within the SIL. Furthermore, in this study we also observed that the region of the cervix the most sensitive to lesion development, the transformation zone, was associated with higher average levels of the immunosuppressive cytokines IL-10 and TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717966      PMCID: PMC1905041          DOI: 10.1046/j.1365-2249.1998.00639.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  52 in total

1.  TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.

Authors:  H Maeda; A Shiraishi
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

Review 2.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma.

Authors:  H Nakagomi; P Pisa; E K Pisa; Y Yamamoto; E Halapi; K Backlin; C Juhlin; R Kiessling
Journal:  Int J Cancer       Date:  1995-11-03       Impact factor: 7.396

4.  Human non-small cell lung cancer cells express a type 2 cytokine pattern.

Authors:  M Huang; J Wang; P Lee; S Sharma; J T Mao; H Meissner; K Uyemura; R Modlin; J Wollman; S M Dubinett
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

5.  TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice.

Authors:  H Maeda; H Kuwahara; Y Ichimura; M Ohtsuki; S Kurakata; A Shiraishi
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

6.  Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.

Authors:  E Tartour; A Gey; X Sastre-Garau; C Pannetier; V Mosseri; P Kourilsky; W H Fridman
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

7.  Serologic response in human papillomavirus-associated invasive cervical cancer.

Authors:  R P Viscidi; Y Sun; B Tsuzaki; F X Bosch; N Muñoz; K V Shah
Journal:  Int J Cancer       Date:  1993-11-11       Impact factor: 7.396

8.  IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines.

Authors:  Y Aragane; H Riemann; R S Bhardwaj; A Schwarz; Y Sawada; H Yamada; T A Luger; M Kubin; G Trinchieri; T Schwarz
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.

Authors:  M Matsuda; F Salazar; M Petersson; G Masucci; J Hansson; P Pisa; Q J Zhang; M G Masucci; R Kiessling
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Expression of interleukin 10 in human melanoma.

Authors:  S Krüger-Krasagakes; K Krasagakis; C Garbe; E Schmitt; C Hüls; T Blankenstein; T Diamantstein
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

View more
  22 in total

1.  Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.

Authors:  Carlos A Ramos; Neeharika Narala; Gayatri M Vyas; Ann M Leen; Ulrike Gerdemann; Erich M Sturgis; Matthew L Anderson; Barbara Savoldo; Helen E Heslop; Malcolm K Brenner; Cliona M Rooney
Journal:  J Immunother       Date:  2013-01       Impact factor: 4.456

2.  Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

Authors:  Jennifer C Guess; Dennis J McCance
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 3.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

4.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

5.  Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.

Authors:  Michael Herfs; Pascale Hubert; Natalia Kholod; Jean Hubert Caberg; Christine Gilles; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

Review 6.  Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Authors:  Sjoerd H van der Burg; Joel M Palefsky
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

7.  Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.

Authors:  Takashi Iwata; Takuma Fujii; Kenji Morii; Miyuki Saito; Juri Sugiyama; Hiroshi Nishio; Tohru Morisada; Kyoko Tanaka; Tomonori Yaguchi; Yutaka Kawakami; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2014-03-01       Impact factor: 3.402

8.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

9.  The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.

Authors:  Maria Alice G Gonçalves; Edson G Soares; Eduardo A Donadi
Journal:  Infect Agent Cancer       Date:  2009-08-18       Impact factor: 2.965

10.  Therapeutic vaccines against human papillomavirus and cervical cancer.

Authors:  Angel Cid-Arregui
Journal:  Open Virol J       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.